이상반응 보고
| VAERS ID | 2296231 |
|---|---|
| 성별 | 여성 |
| 나이 | 22세 |
| 주 코드 | FR |
| 제약회사 | JANSSEN |
| 로트 번호 | XE426 |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-09-01 |
| 발병일 | 2021-09-02 |
| 상태 |
증상
- 두통(Headache)
- 현지 반응(Local reaction)
- 기침(Cough)
- 아게우시아(Ageusia)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
SEVERE LOCAL REACTION; DRY COUGH; TASTE LOSS; HEADACHE; This spontaneous report received from a health care professional via a Regulatory Authority, Regulatory Authority concerned a 22 year old female of unspecified race and ethnic origin.
The patient's height, and weight were not reported.
No past medical history or concurrent conditions were reported.
The patient received covid-19 vaccine ad26.
cov2.
s (suspension for injection, route of admin not reported, batch number: XE426 expiry: unknown) dose was not reported, 1 total, (dose 1) administered on 01-SEP-2021 for an unspecified indication.
Age at time of vaccination 22 years old.
No concomitant medications were reported.
On 02-SEP-2021, the patient experienced severe local reaction, severe dry cough, taste loss, and headache.
The latency period for event severe local reaction was 1 day.
The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
The patient had not recovered from severe local reaction, dry cough, headache, and taste loss.
This report was serious (Other Medically Important Condition).
Sender's Comments: V0: 20220544351-COVID-19 VACCINE AD26.
COV2.
S- SEVERE LOCAL REACTION, DRY COUGH, TASTE LOSS.
The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility.
There is no information on any other factors potentially associated with the event(s).
Therefore, this event(s) is considered unassessable.
20220544351-COVID-19 VACCINE AD26.
COV2.
S-HEADACHE.
This event(s) is labeled and is therefore considered potentially related.